Past exam of the biochemistry and Molecular Biology course of the University of Cambridge / 2025 / Paper 1

The useful product is a correctly identified, active and reproducible protein preparation, not merely a large expression band. I would first examine the coding sequence, protein sequence and available biological information to identify the likely mature chain, protein domains, signal peptides, transmembrane segments, disulfide bonds and required post-translational modifications. A predicted protein structure can guide construct boundaries, but cannot establish that the expressed product will fold or function. A eukaryotic genomic sequence containing introns generally needs replacement by an intron-free Complementary DNA or synthetic coding region for expression in Escherichia coli. I would verify the chosen isoform and full sequence, since a database annotation can be wrong.

The expression host follows from the biochemical requirements. Escherichia coli is inexpensive and convenient for many soluble proteins; yeast, insect or mammalian cells may be preferable for secreted proteins or essential glycosylation. A membrane protein also requires a suitable membrane environment during expression and an appropriate detergent or membrane mimic after extraction. I would preserve biologically necessary domains and modifications. Removing a flexible region to improve yield creates a different construct whose suitability must be justified by the intended analysis.

For a bacterial preparation, I would clone the coding region into an expression vector with a controllable promoter, a suitable ribosome-binding site, a selectable marker and a removable affinity tag. A terminal polyhistidine tag is a practical initial choice, provided the terminus is compatible with activity. Correct reading frame, both junctions and the complete insert must be checked by DNA sequencing. The T7 expression system offers strong inducible expression through a phage RNA polymerase; the original work established selective expression of cloned genes, but strong transcription alone does not guarantee soluble, active product.^[ref]

I would screen small cultures before scale-up, varying induction strength, induction duration and temperature, and comparing total lysate with soluble and insoluble fractions by SDS-PAGE. Empty-vector and uninduced controls identify host bands and background expression; an immunoblot against the tag can help identify the product. Expression at lower temperature or a weaker rate can improve protein folding; persistent insolubility may require changing the construct, host or folding environment. An inclusion body is evidence of abundant insoluble material, not of correctly folded protein. Refolding may be possible, but its yield and recovered activity need independent validation.

Once a small-scale condition produces active soluble material, I would expand the culture or fermentation while monitoring growth and retaining the validated induction conditions. After harvesting, controlled lysis at low temperature, an appropriate buffer solution and protection against proteolysis preserve the product. Centrifugation removes debris; a membrane-associated target instead requires isolation and solubilization of the relevant fraction. I would use immobilized metal affinity chromatography for a polyhistidine-tagged construct, wash away nonspecific binders, and elute under conditions compatible with activity. Tag cleavage, a second affinity step to remove tag and tagged protease, and an orthogonal separation such as ion-exchange chromatography can improve purity. A final size-exclusion chromatography step removes aggregates and separates different assemblies. No single chromatographic peak proves identity or homogeneity.

At each stage I would record protein concentration, total recovered amount and a suitable activity or binding readout, rather than optimizing yield alone. Final checks would include SDS-PAGE, intact or peptide mass spectrometry, a native-size measurement and the expected biological activity. Buffer-only and host-purification controls test whether apparent activity comes from contaminants; comparing tagged and cleaved material tests tag interference. Small frozen aliquots should be used only after checking stability and freeze–thaw effects. Scale-up is justified by recovery of the desired molecular species with retained function, with any differences from the native protein documented.

The same base sequence can present different molecular surfaces in different helical conformations. A-DNA, B-DNA and Z-DNA all retain paired antiparallel strands, but differ in handedness, backbone geometry, sugar puckering and groove accessibility. The familiar dimensions are approximate averages: sequence, hydration and bound molecules change the details, so they are structural signatures rather than rigid constants.

B-DNA is a right-handed DNA double helix with about $10.5$ base pairs per turn, a rise near $0.34\mathrm{nm}$ per pair and a diameter near $2\mathrm{nm}$. Its base pairs lie approximately perpendicular to the helical axis; the sugars are predominantly C2′-endo and the glycosidic bonds are anti. A broad accessible major groove and a narrower minor groove expose different edges of the paired nucleobases. Hydrated duplex DNA commonly adopts this family of conformations, although local bends and groove widths depend on sequence.

A-DNA is also right-handed, but is shorter and wider: roughly $11$ base pairs per turn, a rise around $0.26\mathrm{nm}$ per pair, and a diameter near $2.3\mathrm{nm}$. C3′-endo sugar puckering brings successive phosphates closer along each strand. The base pairs are inclined and displaced from the axis, producing a deep narrow major groove and a broad shallow minor groove. Reduced hydration favours A-DNA. Double-stranded RNA and many DNA-RNA hybrids adopt A-like geometry because the ribose 2′-hydroxyl constrains the backbone; this is important when extending a DNA-only comparison to cellular nucleic acids.

Z-DNA is a left-handed duplex with a zigzag backbone and a two-base-pair conformational repeat. It has approximately $12$ base pairs per turn, a rise near $0.37\mathrm{nm}$ per pair and a diameter around $1.8\mathrm{nm}$. Alternating purine–pyrimidine sequences, especially alternating G and C, favour it under suitable conditions. Purines commonly adopt syn glycosidic bonds and C3′-endo sugars, whereas pyrimidines remain anti with C2′-endo sugars. Its minor groove is narrow and deep, while the conventional major groove is flattened and poorly defined. Atomic-resolution analysis of an alternating CG oligomer established that a duplex can adopt this left-handed fold.^[ref] High salt in a crystal experiment is evidence of an accessible conformation, not proof that most cellular DNA is in that state; negative supercoiling and protein binding can instead favour local transitions.

These geometries determine how proteins read sequence. In B-DNA, the pattern of hydrogen bond donors, acceptors and hydrophobic groups in the major groove distinguishes the four oriented base pairs without strand separation. The minor groove carries less direct chemical information: A–T and T–A present similar patterns there, as do G–C and C–G. Specificity can nevertheless arise from DNA shape readout, including groove width, electrostatic potential, deformability and hydration, combined with contacts to the phosphate backbone. The chemical accessibility of base edges underlies the classic analysis of sequence-specific recognition of duplex nucleic acids.^[ref]

An alpha helix from a transcription factor can fit a B-DNA major groove, but the same docking arrangement need not fit the deep narrow groove of A-DNA. Many double-stranded RNA-binding interactions therefore emphasize backbone or shape, although A-form geometry does not make sequence-specific RNA recognition impossible. A Z-DNA-binding domain can recognize the characteristic left-handed backbone, making recognition partly conformation-specific rather than simply recognition of an exposed base code. In cells, nucleosomes, competing proteins, torsional stress and local hydration further determine access. Binding assays should compare sequences and conformations independently, using structural or spectroscopic controls: a sequence mutation can change both the chemical recognition pattern and the probability of adopting the recognized structure.

Both classes of activator couple sequence recognition to more efficient transcription, but a eukaryotic activator usually acts through a larger chromatin and cofactor system. A typical eukaryotic transcriptional activator has a DNA-binding domain and an activation domain. The former positions it at a regulatory sequence; the latter recruits or regulates other components. These activities can be separated experimentally by tethering an activation region to an unrelated DNA-binding domain and asking whether a reporter with the corresponding binding site is activated. Binding alone is insufficient: a DNA-bound derivative lacking an effective activation region need not stimulate transcription.

In eukaryotes, the target DNA is packaged in chromatin. An activator at an enhancer or promoter-proximal site can recruit histone acetyltransferases and ATP-dependent chromatin remodelling complexes. Histone modification and nucleosome repositioning can increase access to regulatory and promoter sequences; acetylated residues can also recruit reader proteins. These are context-dependent routes, not a universal requirement that every activated gene first undergo the same histone change. Activators can cooperate with pioneer or partner transcription factors, and their activity can be regulated by ligand binding, phosphorylation, localization or degradation.

Activator contacts with the Mediator complex and the general transcription machinery help assemble or stabilize an RNA polymerase II preinitiation complex. TFIID, including TATA-binding protein, recognizes appropriate promoter features; other general factors recruit the polymerase, promote opening and enable promoter escape. Regulatory contacts may additionally influence release of paused polymerase and productive elongation. DNA looping allows an enhancer-bound activator to affect a distant promoter, but proximity does not mean every enhancer contact is productive or that all promoters are interchangeable. Biochemical reconstitution showed that a mediator fraction was required for activated transcription in vitro, providing evidence that activator–polymerase communication can require an intermediate rather than a direct DNA-to-polymerase contact.^[ref]

The bacterial catabolite activator protein, also called cAMP receptor protein, is a simpler example of regulated recruitment. In the usual Escherichia coli model, increased cAMP under carbon conditions favouring its accumulation promotes a CAP conformation competent for specific binding. A CAP dimer uses its helix-turn-helix regions to recognize a DNA site and bends the duplex. At a class I CAP-dependent promoter such as the canonical lac arrangement, a site centred near $-61.5$ positions an activating surface to contact the C-terminal domain of the RNA polymerase alpha subunit. This stabilizes polymerase recruitment; the CAP–alpha-domain–DNA structure supplies a direct molecular basis for that contact.^[ref]

CAP is not limited to that single geometry. At class II promoters, a site near $-41.5$ overlaps the promoter region and permits additional contacts with polymerase, affecting more than initial recruitment. Promoter position, orientation and other repressors therefore matter. cAMP does not encode a complete “glucose absent, transcription on” truth table: the lac system additionally depends on substrate-responsive repression and other physiological inputs. An activating protein can improve a limiting step without determining the entire expression pattern.

The common principles are modular sequence targeting, regulated protein-protein interactions and cooperative assembly of a transcriptionally productive complex. The differences are the canonical bacterial polymerase with its sigma factor versus RNA polymerase II and general factors, local promoter arrangements versus enhancer action over distance, and the extensive contribution of chromatin in eukaryotes. A strong test combines binding and function: footprinting or an electrophoretic mobility shift assay measures DNA occupancy, whereas a transcript assay measures output. An activation-surface mutant that retains DNA binding but loses transcriptional stimulation separates recruitment from recognition. In a reconstituted system, removing and restoring a required cofactor tests causality; in cells, changes in chromatin or reporter activity alone do not identify the direct protein contact.

RNA structure controls which ribosome-binding and decoding events are kinetically accessible. A bacterial messenger RNA can base-pair with itself or other RNA molecules, forming alternative structures whose populations depend on sequence, ligand concentration, temperature and translating ribosomes. Its sequence consequently encodes both a polypeptide and part of the mechanism controlling production of that polypeptide.

At initiation, a stem can sequester the Shine-Dalgarno sequence or start region, reducing pairing with the anti-Shine-Dalgarno region of the small-subunit ribosomal RNA and preventing productive initiation. Opening that structure makes the same coding sequence more accessible. Start-site accessibility also matters in bacteria whose transcripts do not use a canonical Shine-Dalgarno sequence; not all bacterial initiation can be reduced to this one motif. The regulatory variable is often competition between folding, unfolding and ribosome binding rather than a permanently closed structure.

A riboswitch couples a ligand-binding RNA domain to an expression platform that can alternatively expose or hide a translation-initiation region. Binding of a metabolite can stabilize one structure without requiring a separate regulatory protein. Direct binding of thiamine derivatives to bacterial messenger RNA established an RNA-based route to metabolic regulation.^[ref] In an RNA thermometer, heating destabilizes a stem and exposes the initiation site. The FourU thermometer provides a concrete example in which uridines help pair with the ribosome-binding region of a heat-responsive transcript.^[ref] Sequence specificity and a biologically relevant transition range distinguish such a sensor from the nonspecific fact that all RNA eventually denatures on heating.

Trans-acting small regulatory RNAs can remodel target messenger RNA structure by base pairing. Some block initiation directly, often aided by the RNA-binding chaperone Hfq; others disrupt an inhibitory stem and activate translation. Pairing can also expose an ribonuclease cleavage site or recruit degradation machinery. Protein-binding regulators provide another route: a ribosomal protein can recognize a structured element in its own polycistronic transcript and repress excess ribosomal-protein production. Occupancy of a structured site thus links translation to stoichiometric demand.

In a polycistronic messenger RNA, translation of an upstream coding region can unwind a structure masking a downstream initiation site, producing translational coupling. During elongation, the ribosome can unwind many structures, but a sufficiently resistant downstream RNA pseudoknot or stem, combined with an appropriate slippery sequence, can promote programmed ribosomal frameshifting. This changes the reading frame and hence the ratio of distinct protein products. Structure can also influence recoding or pause positions; a predicted stable hairpin alone does not establish that a physiologically meaningful pause occurs.

RNA structure further couples translation to transcription. In the tryptophan attenuation in bacterial gene regulation mechanism, rapid or stalled translation of a leader peptide changes which alternative RNA stems form. This decides formation of a transcription terminator and therefore how much downstream transcript is available. The immediate switch is termination of transcription, even though ribosome movement and structured RNA generate the decision. Likewise, intrinsic terminator formation, transcript degradation and ribosome protection change protein output without necessarily changing translation efficiency per intact transcript.

A convincing experiment measures both transcript abundance and protein output. Fuse the regulatory region to a reporter while retaining a control promoter; compare ligand or temperature conditions with a construct lacking the proposed structural element. A mutation disrupting one side of a stem, followed by a compensatory mutation restoring pairing with a changed sequence, distinguishes pairing from a single nucleotide-specific contact. RNA structure probing can test accessibility directly, and toeprinting can report initiation-complex occupancy. Include controls for reporter folding, growth, RNA half-life and effects of the perturbation on the ribosome itself. These tests connect a structural transition to the appropriate mechanistic step rather than assuming every change in protein abundance is a change in initiation.

A purified sample should be characterized along independent axes: identity, amount, chemical integrity, solution assembly, conformation and function. A high-resolution structural experiment cannot compensate for analysing the wrong protein or a mixture of molecular states. Conversely, useful biochemical information does not require an atomic structure.

First, verify identity and integrity. SDS-PAGE under reducing and nonreducing conditions estimates apparent subunit size and reveals many contaminants or disulfide-linked species. A single band cannot exclude a same-sized contaminant, a small chemical modification or several co-migrating oligomers. An immunoblot adds epitope recognition, while peptide mass spectrometry checks sequence-derived peptides and intact-mass analysis tests the overall molecular mass. Comparing measured and predicted masses can reveal cleavage, retained tags or modifications, but incomplete peptide coverage and heterogeneity constrain the inference. A tag-specific signal establishes the tag's presence rather than the identity of every residue.

Measure protein concentration using absorbance and an appropriate extinction coefficient, or a calibrated colorimetric assay with compatible standards. The Beer-Lambert law, $A=\epsilon lc$, converts absorbance to concentration only when the assumed molecular species and optical conditions apply. tryptophan residues, tyrosine residues and disulfides contribute to ultraviolet absorption; light scattering and nucleic-acid contamination can inflate readings. Buffer blanks, dilution linearity and a second quantification method help identify such problems. A concentration stated as monomer equivalents must not be confused with the concentration of oligomeric particles.

Next, determine whether the material is monodisperse and how it assembles in solution. Size-exclusion chromatography reports hydrodynamic size and can separate aggregates, but elution calibrated with globular standards gives an apparent size, not an absolute molecular mass for an elongated protein. SEC-MALS combines separation with multi-angle light scattering and a concentration detector to estimate the molar mass across the eluting peak; it can distinguish a large monomer from a compact oligomer when the detector models and sample composition are suitable.^[ref] Analytical ultracentrifugation supplies a complementary sedimentation-based approach, and concentration series can reveal reversible association. dynamic light scattering is sensitive to aggregates but is strongly influenced by a small number of large particles; a visually narrow intensity distribution is not a precise count of all molecular species.

Conformation and stability can then be assessed without determining an atomic model. Far-ultraviolet circular dichroism reports ensemble secondary-structure features, while near-ultraviolet circular dichroism and intrinsic aromatic fluorescence probe environments associated with tertiary packing. These signatures support folding and conformational changes but do not uniquely specify a three-dimensional fold. Thermal or chemical unfolding followed spectroscopically estimates stability only within an appropriate model: an irreversible aggregation-driven transition does not give an equilibrium folding free energy. Differential scanning calorimetry measures heat-capacity changes during a transition, and limited proteolysis can reveal exposed regions or stable domains. Buffer-only controls, matched concentrations and repeated heating–cooling cycles help separate reversible conformational change from precipitation.

Finally, test biological competence. For an enzyme, initial-rate measurements over substrate and enzyme concentration ranges establish specific activity and, where justified, Michaelis-Menten kinetics. For a binding protein, isothermal titration calorimetry can estimate binding stoichiometry, affinity and enthalpy, while a kinetic method such as surface plasmon resonance can resolve association and dissociation. Controls must include heat of dilution or nonspecific surface binding, ligand quality and the possibility of multivalent avidity. A measured dissociation constant does not by itself establish physiological function.

The methods should be chosen to answer a defined question and cross-check one another. For example, a clean gel, the expected intact mass, a single SEC-MALS species and concentration-independent native activity jointly support a useful preparation; none establishes complete homogeneity alone. Comparing fresh, stored and freeze–thawed samples identifies conditions suitable for later structural work. The resulting dossier should state what species is present under the actual experimental conditions and which features remain unresolved.

Directed evolution searches experimentally for useful sequences; rational design proposes changes from a mechanistic model. Their strengths are complementary. Both require a clear target phenotype and a reliable assay. “Improved” must mean improvement in a relevant property, such as catalytic efficiency in the intended solvent, rather than simply more expression or a larger reporter signal.

In directed evolution, a parent gene is diversified by error-prone PCR, recombination or targeted mutagenesis. Each variant must remain linked to the activity it encodes, for example in a separate bacterial clone or an appropriate display or compartmentalization system. A screening assay measures individual variants, whereas a selection assay allows successful variants preferential survival or recovery. Improved variants seed another cycle. Maintaining this genotype-phenotype linkage is essential: a diffusible product shared between cells could otherwise reward inactive neighbouring variants.

A classic example is evolution of subtilisin E for activity in dimethylformamide. Sequential random mutagenesis and screening found combinations of substitutions that improved performance in an environment outside the native enzyme's usual conditions. The result illustrates that useful mutations need not be obvious from the catalytic-site structure: they can alter stability, solvent interactions or the conformational ensemble.^[ref] To identify the reason for an improved clone, I would compare purified variants at equal active-enzyme concentration, measure activity and stability separately, and reconstruct individual and combined substitutions. Otherwise increased secretion, expression or resistance to the assay conditions could masquerade as altered intrinsic catalysis.

The advantages of directed evolution are that it can exploit effects too complicated to predict and optimize several coupled properties in the actual assay environment. Its limitations are experimental throughput, the availability of a starting activity and a faithful assay. The accessible sequence space is tiny relative to all possible proteins. Epistasis means that combining individually beneficial substitutions may fail, and a series of local improvements may miss a route requiring a temporarily deleterious intermediate. Selection on an easy surrogate substrate can improve the surrogate while failing on the intended substrate. A large library does not rescue an assay that measures the wrong property.

rational protein design instead uses sequence comparisons, structural information and chemical reasoning to propose changes. Examples include repositioning a catalytic group, reshaping a binding pocket, introducing a stabilizing interaction or removing a reactive surface residue. A focused set of site-directed mutagenesis is easier to interpret and cheaper to test than a vast random library when the relevant mechanism is understood. It can also create an initial active site for chemistry that the parent does not catalyse detectably. However, the accuracy of the proposal depends on treatment of folding, water, electrostatics, dynamics and the difference between substrate binding and transition-state stabilization.

Computational Kemp eliminase design provides a useful comparison with the subtilisin case. Designed active sites placed a base in a scaffold to promote proton abstraction in Kemp elimination, creating experimentally measurable catalytic activity. Subsequent directed evolution improved the designs, demonstrating that the initial geometric model captured useful chemistry but did not fully optimize the physical enzyme.^[ref] For a designed catalyst, controls should include the unmodified scaffold, removal of the proposed catalytic residue, no-enzyme reactions and direct product identification. A bound substrate, a plausible predicted structure or increased fluorescence from a reporter is not by itself evidence for the intended reaction mechanism.

A productive combined strategy uses rational knowledge to choose scaffolds and library positions, then lets directed evolution explore variants under the desired conditions. Sequencing and biophysical characterization of the successful variants can then improve the design model. Prediction focuses the search; controlled experiments decide whether the resulting protein actually has the desired function. Neither approach eliminates the need to assess trade-offs among activity, stability, specificity and manufacturability.

The liver uses glucose sensing chiefly to regulate fuel storage and production, while pancreatic beta cells convert glucose availability into an endocrine signal. The comparison therefore includes transport, metabolism and allosteric control; it should not identify one transporter as the complete sensor in either tissue.

glucokinase phosphorylates glucose to glucose-6-phosphate in both hepatocytes and pancreatic beta cells. Unlike many other hexokinases, it is not strongly inhibited by its product and operates over a higher glucose range. Its monomeric enzyme nevertheless shows a sigmoidal steady-state response to glucose, arising from its kinetic conformational behaviour rather than cooperative binding between several subunits. A glucose half-saturation concentration in the physiological millimolar range makes its flux responsive to changing blood glucose, whereas a low-affinity constant cannot alone establish the in vivo sensing step without considering transport and downstream metabolism.

In beta cells, glucose metabolism through glycolysis and mitochondrial oxidation increases the cellular ATP-to-ADP state. ATP-sensitive potassium channels then close: ATP inhibits the Kir6.2 pore, while Mg-nucleotide effects mediated through SUR1 additionally regulate opening. Reduced potassium conductance produces depolarization, opening voltage-gated calcium channels. Calcium entry triggers exocytosis of insulin-containing secretory granules. Thus the channel senses nucleotides downstream of glucose metabolism; it does not bind extracellular glucose as its initiating ligand. Metabolic amplification and other signals also regulate the amount secreted, so this triggering pathway is necessary context rather than a complete description of every phase of insulin secretion.

glucokinase helps set the glucose threshold for that response. An activating glucokinase mutation associated with familial hyperinsulinism provides evidence that shifting the enzyme's glucose responsiveness can shift whole-body insulin control.^[ref] To separate this interpretation from altered expression, the variant's kinetics should be compared with the normal enzyme and its effect on secretion assessed at matched expression. Inhibiting the potassium channel downstream can bypass part of the sensing chain, whereas preventing calcium entry tests the final electrical-to-secretory coupling.

Glucose transport must be discussed with species in mind. GLUT2 is the prominent transporter in the classical rodent beta-cell model, but human beta cells use predominantly GLUT1 rather than sharing the same abundance of GLUT2. Direct comparison of human and rat preparations found much lower GLUT2 abundance in human cells while glucokinase retained a comparable influence on glucose utilization.^[ref] A transport step with capacity greater than phosphorylation can allow intracellular glucose availability to track the external supply, leaving glucokinase as a major metabolic control point. These observations argue against presenting rodent GLUT2 expression as a universal human sensing mechanism.

In the liver, GLUT2 supports rapid bidirectional facilitated transport. Hepatic glucokinase traps abundant glucose as glucose-6-phosphate, supplying glycogenesis and other metabolic pathways after feeding. glucokinase regulatory protein adds tissue-specific control: at low glucose it binds and sequesters glucokinase in the nucleus; increased glucose promotes release and cytoplasmic use. fructose-6-phosphate favours the inhibitory interaction, while fructose-1-phosphate antagonizes it, coordinating glucose trapping with nutrient context. Hormonal regulation of glucokinase expression adds a slower level of control. Unlike the beta-cell response, the immediate output is a change in hepatic metabolic flux, not release of insulin.

The liver also has an important direct glucose sensor in glycogen phosphorylase. Binding of glucose to liver glycogen phosphorylase a favours an inactive conformation and its dephosphorylation by protein phosphatase 1. Loss of phosphorylase-a activity switches off glycogenolysis and relieves its inhibitory influence on glycogen-synthase phosphatase activity, helping activate glycogen synthase. Glucose administration experiments observed phosphorylase inactivation preceding synthase activation, supporting an ordered switch rather than simultaneous independent responses.^[ref] This direct allosteric route is distinct from glucokinase-mediated metabolic sensing and complements insulin signalling. Together they suit an organ that must stop exporting and begin storing glucose when supply rises, while beta-cell sensing coordinates that transition across multiple tissues.

In vivo muscle NMR reveals energy-buffer use, phosphate chemistry and recovery kinetics without repeatedly removing tissue. It measures visible metabolites, not metabolic flux automatically. A particularly informative experiment is localized ${}^{31}\mathrm{P}$ nuclear magnetic resonance, with a limb positioned in a magnet and a radiofrequency coil over the exercising muscle. Repeated spectra can be collected at rest, during a defined workload and throughout recovery. Localization and synchronized contraction reduce motion artefacts and contamination from inactive tissue.

The resting ${}^{31}\mathrm{P}$ spectrum resolves phosphocreatine, inorganic phosphate and the phosphate resonances of ATP, together with some other phosphorus-containing metabolites. Peak areas, after correcting for excitation and relaxation effects, report relative quantities of NMR-visible pools. An external reference or another justified calibration is needed for absolute concentrations. Large phosphocreatine stores relative to ATP illustrate a buffering system, but a resting spectrum alone does not reveal how fast ATP is synthesized or consumed.

During exercise, creatine kinase buffers ATP throughConsequently phosphocreatine often falls and inorganic phosphate rises while ATP remains comparatively stable during moderate exercise. Stable ATP does not mean little ATP turnover: it can mean rapid replenishment matching rapid consumption. Serial spectra relate changes in the phosphocreatine-to-phosphate ratio to workload and fatigue. Gated human-muscle experiments directly demonstrated such workload-dependent energetic responses.^[ref]

The chemical shift of inorganic phosphate relative to phosphocreatine depends on its protonation state and therefore permits an estimate of intracellular pH. With appropriate calibrated acid and base endpoint shifts, a commonly used relation has the formThe observed shift must lie between the calibration endpoints, and the relevant calibration depends on experimental conditions. Exercise-related acidification and its recovery can therefore be followed alongside the energy-buffer changes. A resolved pair of phosphate signals may indicate metabolically distinct compartments; fitting one average shift to a mixed signal can conceal heterogeneity. A pH fall is not simply a direct lactate measurement, because proton production, consumption, buffering and export all contribute.

If creatine kinase is close to equilibrium, measured ATP and phosphocreatine, together with estimates of total creatine, pH and free magnesium, can constrain free cytosolic ADP. This is an inference from an equilibrium model rather than a direct ADP peak measurement. The corresponding ATP hydrolysis free energy depends on metabolite activities through $\Delta G=\Delta G^{\circ \prime }+RT\ln ([\mathrm{ADP}][P_i]/[\mathrm{ATP}])$ at the specified biochemical conditions. Concentration ratios and a consistent standard-state convention are essential when using this expression quantitatively.

After exercise, oxidative ATP production replenishes phosphocreatine. Recovery is often summarized by $\mathrm{PCr}(t)={\mathrm{PCr}}_{\mathrm{end}}+\Delta \mathrm{PCr}(1-e^{-t/\tau })$, making the initial recovery rate $\Delta \mathrm{PCr}/\tau$. With adequate oxygen delivery and suitable pH conditions, recovery kinetics provide an index of oxidative capacity. Slow recovery may instead reflect impaired perfusion, severe acidification or continuing ATP demand, so it does not uniquely identify a mitochondrial enzyme defect. Work-matched comparisons, adequate rest, reproducible exercise and independent perfusion or oxygenation measurements strengthen interpretation.

Related experiments extend the information available. ${}^1\mathrm{H}$ spectroscopy can detect additional metabolites or lipid pools, while ${}^{13}\mathrm{C}$ experiments can follow labelled substrate incorporation or glycogen under suitable sensitivity conditions. Magnetization-transfer experiments can probe exchange, but exchange rates need not equal net ATP-production flux. The strength of the method is the time-resolved connection between muscle function and intracellular chemistry, with explicit limits from spatial averaging, sensitivity, calibration and the biochemical model used to interpret each signal.

Photoprotection must regulate both the total excitation arriving at reaction centres and its distribution between the two photosystems. When light absorption exceeds the capacity for productive electron transfer and carbon metabolism, excited chlorophyll and reduced electron carriers persist. Triplet chlorophyll can generate singlet oxygen, while inappropriate electron transfer to oxygen can generate other reactive oxygen species. These can damage pigments, lipids and proteins, including photosystem reaction centres. Excess light and unbalanced excitation are related but distinct problems.

The fastest major response to excess light in many plants is energy-dependent non-photochemical quenching. Electron transport builds a proton gradient across the thylakoid membrane, acidifying the lumen. Protonation-dependent changes involving PsbS and antenna proteins favour harmless dissipation of excitation as heat. The xanthophyll cycle contributes: under lumen acidification, violaxanthin de-epoxidase converts violaxanthin through antheraxanthin towards zeaxanthin, altering antenna quenching properties. In dimmer conditions these changes can reverse. Quenching therefore reduces the excitation reaching photosystem II before every captured photon becomes a potentially damaging charge-separation event.

An Arabidopsis mutant lacking normal PsbS-dependent behaviour showed a major loss of rapidly inducible quenching despite retaining light-harvesting capability; this separates a protective antenna-control function from the ability to absorb light.^[ref] A convincing interpretation compares absorbed light, pigment content, baseline photosynthetic competence and restoration by complementation. Reduced chlorophyll fluorescence alone is not sufficient evidence of protective heat dissipation: photochemical use of excitation and irreversible damage can also change fluorescence. Saturating-pulse measurements help separate photochemical and non-photochemical components.

photosynthetic control at the cytochrome b6f complex provides another response to lumen acidification, slowing electron delivery towards photosystem I and limiting excessive reduction of its acceptor side. cyclic electron flow around photosystem I returns electrons to the intersystem chain, supporting proton-gradient formation and ATP production without net NADPH production. This can adjust the ATP-to-reductant supply and reinforce quenching; it is not simply a way of making more NADPH. Mutant analysis linking PGR5-dependent electron-flow regulation to photoprotection supports the connection between electron allocation and protection.^[ref] Alternative electron sinks, including oxygen-reducing pathways, can relieve pressure under some conditions, but require antioxidant systems because oxygen chemistry can itself be damaging. photorespiration also consumes energy and reducing capacity in appropriate conditions. These routes differ across photosynthetic lineages and are not interchangeable universal safety valves.

Unequal excitation requires redistribution. Preferential excitation of photosystem II reduces the plastoquinone pool, signalling an imbalance in electron supply to photosystem I. In plant photosynthetic state transitions, activation of the STN7 kinase promotes phosphorylation of a mobile fraction of LHCII, decreasing excitation delivery to photosystem II and increasing its functional association with photosystem I. When the plastoquinone pool becomes more oxidized, dephosphorylation favours the reverse allocation. This balances excitation rather than dissipating all of it. A kinase-deficient Arabidopsis mutant defective in state transitions demonstrates the requirement for STN7 in this response.^[ref]

State transitions can be tested by switching light preferentially exciting the two photosystems, measuring reversible fluorescence changes and antenna phosphorylation, and comparing wild type, mutant and complemented material. The same experiment should assess electron-transfer capacity so that loss of a state-transition signal is not confused with nonspecific photosynthetic failure. Different algae can use different antenna organizations, and cyanobacterial redistribution need not follow the plant LHCII mechanism. If photosystem I is preferentially excited, the reverse redox signal favours a greater share of antenna excitation reaching photosystem II.

Other short-term protections include carotenoid quenching of triplet chlorophyll or singlet oxygen, antioxidant removal of reactive products, and chloroplast avoidance movements that reduce absorbed light. Replacement of damaged D1 protein repairs photosystem II on a slower short-term timescale; it compensates for damage rather than preventing the original photochemical injury. Rapid quenching, reversible antenna redistribution, electron-flow control and repair therefore address different failure points. A protected organism keeps excitation, electron flow and metabolic demand sufficiently coordinated to avoid prolonged damaging states, rather than merely maximizing light capture.

Gating controls when an ion pathway is available; selectivity controls which ions can use it. An open ion channel permits passive movement down an electrochemical gradient. Opening does not itself specify current direction or guarantee a net current at the reversal potential. At a simple level, a population current can be written $I=N{P}_o\gamma (V-E_{\mathrm{rev}})$, separating channel number, open probability, single-channel conductance and driving force.

In a typical voltage-gated potassium channel, four subunits each contain six transmembrane helices. The S1–S4 region forms a voltage-sensing domain; S4 carries regularly spaced positive charges. A change in membrane potential alters the relative free energies of voltage-sensor conformations. Sensor rearrangement is coupled to opening of the S5–S6 pore region, including its intracellular activation gate. The charges do not have to traverse the entire membrane as free ions: protein conformational changes redistribute them through the electric field. A simple two-state approximation giveswhere $z_g$ is an effective gating charge and the sign convention makes depolarization favour opening for $z_g>0$. Real channels usually have multiple closed states and more complex kinetics.

voltage-gated sodium channels have four homologous domains in one polypeptide, with related voltage sensors and a central pore. Activation is followed by inactivation, which is a distinct process from the activation gate closing when the membrane repolarizes. Calcium channels share a related architecture. Voltage clamp can separate activation and inactivation kinetics, while gating-current measurements and voltage-sensor mutations test coupling between charge movement and pore opening. A mutation that abolishes current must be checked for expression and membrane delivery before concluding that it identifies the gate.

For potassium selectivity, the narrow selectivity filter contains backbone carbonyl oxygens arranged to coordinate largely dehydrated potassium ions. Binding and permeation balance the energetic cost of shedding water against favourable coordination within the filter. Sodium is smaller, but does not receive the same stabilization in the potassium-selective environment, so selectivity is not explained by a rigid hole that rejects all larger ions and admits all smaller ones. The KcsA structure established a concrete molecular basis for this principle.^[ref] KcsA itself is not the canonical S4 voltage-gated channel: its pore illustrates a conserved selectivity mechanism, not the voltage sensor just described. Voltage-gated sodium channels use a different filter chemistry; eukaryotic calcium-channel filters favour divalent calcium through an acidic coordination environment.

A ligand-gated ion channel instead couples ligand occupancy to changes in pore-opening probability. The nicotinic acetylcholine receptor is a pentamer with extracellular ligand-binding interfaces and a pore lined by M2 helices. Acetylcholine binding favours an opening-associated conformational change transmitted through the extracellular-to-transmembrane interface. Its pore conducts cations, including sodium and potassium, rather than selectively conducting only the transmitter or only sodium. Negatively charged regions and pore geometry favour cation over anion permeation. The ligand-binding site and the ion-selective pathway are spatially distinct, so the chemical identity of the bound transmitter does not define the permeant ion.

Rapid agonist exposure followed by freezing of Torpedo receptor membranes captured an opening-associated conformation, experimentally connecting ligand application to a receptor structural state.^[ref]

Other ligand-gated channels illustrate the independence of these properties: GABA-A receptors primarily support anion conductance, while glutamate-receptor channels support cation conductance with subtype-dependent calcium permeability. A sustained agonist can produce channel desensitization, in which an occupied receptor becomes nonconducting; occupancy is therefore not a permanently open instruction. Intracellular ligands can gate other channels, including ATP-dependent regulation, so “ligand-gated” need not imply an extracellular neurotransmitter.

The decisive tests separate binding, gating and permeation. Patch clamp resolves individual opening and closing events; rapid ligand application measures activation and desensitization; ion substitution and reversal-potential measurements constrain relative permeability. Changing a filter residue while retaining agonist binding and surface expression can implicate selectivity, while changing binding-site affinity without changing unitary conductance suggests a different role. Appropriate controls include leakage currents, solution junction potentials, channel abundance and ionic activities. A structure supplies candidate mechanisms; state-dependent electrophysiology establishes what those mechanisms do.

Frog oocytes and egg extracts turned cell-cycle regulation into a transferable biochemical activity that could be purified, removed, restored and followed through time. Xenopus laevis provides large oocytes and abundant eggs containing stockpiled proteins and maternal messenger RNA. Early embryonic cycles can alternate rapidly between DNA replication and mitosis with little or no intervening growth phases. This makes extracts powerful for reconstructing the core oscillator, while also limiting direct extrapolation to the checkpoints and growth control of a differentiated somatic cell.

An immature oocyte is arrested in meiotic prophase. Hormonal stimulation can induce germinal-vesicle breakdown and progression towards a mature egg. Cytoplasm from a mature donor can induce maturation after injection into an immature recipient, establishing that a cytoplasmic activity can drive nuclear events. The activity was termed maturation-promoting factor, later also called M-phase-promoting factor. The foundational transfer experiments were performed in another frog species, Rana pipiens, so they should not be misattributed specifically to Xenopus.^[ref] Xenopus subsequently made the activity accessible to extensive extract assays and biochemical purification. Serial transfer also suggested amplification, rather than transfer of a fixed stoichiometric amount of a structural nuclear component.

Crushing unfertilized Xenopus eggs yields cytoplasm in which added nuclei can undergo characteristic mitotic events. Assay-guided fractionation of this material purified an activity capable of promoting early mitotic changes, making a connection between a cytoplasmic functional assay and specific protein components.^[ref] MPF is the complex of CDK1, historically Cdc2, with a mitotic cyclin such as cyclin B. The cyclin is a regulatory partner; CDK1 is the catalytic kinase. Nuclear-envelope breakdown, chromosome condensation and histone H1 kinase assays give complementary outputs. Co-purification with kinase activity is stronger when supported by immunodepletion and restoration of the active complex, because crude H1 phosphorylation is not uniquely specific to CDK1.

Cyclin synthesis and destruction provide the changing input. Cycling extracts show cyclin accumulation followed by destruction around mitotic exit. Blocking protein synthesis prevents repeated cycles; supplying appropriate cyclin material can restore mitotic entry, while a nondegradable cyclin prevents normal exit. These interventions distinguish association from a causal requirement for periodic synthesis and destruction.^[ref] Cyclin destruction is mediated by the anaphase-promoting complex, an ubiquitin ligase, followed by proteasomal degradation. It is therefore regulated proteolysis, not dilution or loss of kinase protein, that helps reset the mitotic machinery. Destruction of additional substrates coordinates chromosome separation with exit.

The response is not determined by cyclin concentration alone. Inhibitory CDK1 phosphorylation by Wee1 opposes activation; Cdc25 removes inhibitory phosphates. Active CDK1 promotes Cdc25 and suppresses Wee1, creating positive feedback. Xenopus extract experiments approaching the same sustained cyclin dose from an initially low or high kinase state found different maintained outputs, providing evidence of cell-cycle hysteresis experiment.^[ref] Monitoring endogenous cyclin destruction and the persistence of the added nondegradable input controls the possibility that the two histories merely leave different amounts of cyclin. This explains how gradual accumulation can produce a decisive transition rather than requiring every molecule to respond linearly.

Unfertilized eggs also reveal regulated arrest. They remain in meiotic metaphase II through cytostatic factor activity, which restrains the machinery for cyclin destruction. A fertilization-associated calcium signal releases that arrest, permitting cyclin destruction and meiotic completion. Experimentally adding calcium to an appropriately arrested extract can mimic this switch; a sham addition and monitoring cyclin and nuclear responses separate a genuine cycle transition from nonspecific extract damage.

Egg extracts additionally allow replication licensing to be separated from subsequent initiation. Added sperm chromatin can assemble nuclei and replicate, while transfer between extracts and manipulation of kinase state test why DNA is copied once per cycle. Licensing is permitted in a low-CDK state, while initiation-associated high CDK activity helps prevent relicensing before mitotic exit. A completed round of DNA synthesis must be distinguished from repair synthesis or simple nucleotide incorporation by appropriate product and template controls. The central contribution of Xenopus is experimental causality: a conserved cyclin–kinase system, feedback-controlled transitions, regulated proteolysis and replication control can be dissected in a cell-free cytoplasm rather than inferred only from correlations in dividing cells.

Retrovirus studies showed that a transmissible agent can cause a tumour and, more unexpectedly, that a viral transforming gene can derive from an ordinary cellular gene. This connected infectious cancer models to the molecular control of normal cell growth.

Peyton Rous transmitted a chicken sarcoma using material from a tumour and showed that a cell-free filtrate could transmit the disease. The agent could therefore be separated from intact tumour cells, arguing against simple transplantation of the malignant cells as the explanation.^[ref] This established a filterable tumour-causing agent, not yet its RNA genome, replication mechanism or a claim that every cancer is infectious. In repeating such an experiment, an uninoculated or sham-treated group and a preparation verified to lack viable donor cells would be essential comparators; host susceptibility and the preparation's retained infectivity would also matter.

The later Rous sarcoma virus system made transformation experimentally tractable. Infected cultured fibroblasts can lose contact inhibition, change morphology and form foci against a background of untransformed cells. Such assays distinguish efficient transformation from the slower and more complex endpoint of tumour formation in an animal. Temperature-sensitive transforming mutants allow the phenotype to be switched by changing conditions, while transformation-defective viruses can still replicate. This separates a transforming function from the basic machinery required to produce virus.

The retroviral life cycle explains persistent genetic change. Viral RNA is copied into DNA by reverse transcriptase; the resulting DNA can integrate into the cellular genome as a provirus. Demonstration of RNA-dependent DNA synthesis in Rous-virus particles gave biochemical support to this route of information transfer.^[ref] Template dependence, nuclease sensitivity and controls for contaminating cellular enzymes are needed to infer an RNA-templated polymerase rather than merely observe incorporation of labelled nucleotides. Integration then allows stable expression of viral genes through ordinary cellular transcription.

Comparison of transforming and transformation-defective viral genomes identified v-src as a transforming determinant. A crucial next question was whether src-like sequence existed only in tumour viruses. A probe enriched for transformation-specific viral sequences hybridized to DNA from normal birds, including multiple avian species. This showed that related information was present in normal cellular genomes, with evolutionary conservation rather than only virus-associated occurrence.^[ref] The cellular counterpart, c-src, is a proto-oncogene: a normally regulated cellular gene that can become oncogenic when its expression or activity is altered. Viral capture and modification of cellular growth-control information therefore explain why a virus can carry a potent growth-deregulating gene.

The Src product linked genotype to a biochemical mechanism. Its kinase activity was shown to phosphorylate tyrosine residues, establishing an unusual regulatory chemistry at the time and connecting transformation to deregulated protein phosphorylation.^[ref] The viral product has altered regulation compared with normal cellular Src, so persistent signalling can disrupt growth, adhesion and cytoskeletal control. The lesson is not that a normally expressed proto-oncogene is inherently malignant: context, dosage and regulatory state matter. Immunoprecipitate kinase assays need controls because an associated kinase could otherwise be mistaken for the precipitated protein's catalytic activity; biochemical and genetic tests strengthen the attribution.

Other retroviruses supplied a second route. Slowly transforming avian leukosis viruses need not carry a captured oncogene; integration near a cellular gene can alter its expression through viral regulatory sequences. Promoter-insertion studies of the MYC proto-oncogene demonstrated this principle.^[ref] Recurrent integrations near the same gene across independent tumours provide more persuasive evidence than one integration in one tumour, and expression and functional tests help distinguish a driver event from an incidental integration.

Together these experiments established separable mechanisms of viral oncogene acquisition and insertional oncogenesis, revealed cellular proto-oncogenes and identified deregulated signalling as a cause of transformation. They do not imply that retroviral integration explains every tumour, or that a transformed culture has all the properties of an invasive cancer. Their wider importance is that normal growth-regulatory genes, when altered, can drive malignant behaviour even outside the original infectious setting.

Colonumab would have to be defined by its molecular target, functional mechanism and sequence before its proposed name conveys any useful scientific information. Colon cancer is not a single unique antigen. I would begin by selecting a target expressed accessibly on the relevant tumour cells and asking whether binding should block a growth signal, recruit immune effectors or deliver a payload. A surface receptor tyrosine kinase such as the epidermal growth factor receptor is a possible mechanistic starting point, but it is also expressed in normal tissue. Differential abundance, tissue accessibility, heterogeneity and the consequences of blocking the target must therefore be tested, rather than assuming tumour selectivity.

Target validation should compare tumour specimens, relevant normal tissues, cancer cell lines and appropriate primary-cell or organoid models. Binding to a recombinant extracellular domain is useful, but a candidate should also recognize the native membrane target. Target knockout and restoration provide strong specificity controls, and testing an independently binding antibody helps distinguish loss of the target from a damaged assay. For a signalling-blocking candidate, downstream pathway responses and growth must be measured; receptor expression alone does not establish dependence on that pathway. A tumour with constitutive downstream signalling may resist receptor blockade even if the antibody binds well.

One generation route is hybridoma technology. An immunized animal supplies B lymphocytes recognizing the chosen antigen. Fusion with an immortal myeloma line can produce hybrids that combine continued proliferation with antibody secretion. The classic experiments established continuous cultures secreting antibodies of predefined specificity.^[ref] In the conventional HAT selection scheme, aminopterin blocks de novo nucleotide synthesis; an appropriate salvage-pathway-deficient myeloma parent cannot survive alone, while unfused primary B cells have limited lifespan. Suitable hybrids inherit functional salvage metabolism and immortality. HAT survival does not select the desired antigen specificity: supernatants must subsequently be screened.

I would screen many clones for binding to native target-positive cells, absence of binding to matched target-negative cells, suitable epitope and the desired functional effect. Single-cell cloning and sequence analysis establish a defined monoclonal product. Heavy- and light-chain variable sequences can then be recovered and expressed recombinantly. A mouse-derived antibody might be made chimeric by joining its variable regions to human constant regions, or humanized by grafting selected complementarity-determining regions onto suitable human frameworks. CDR grafting demonstrated that binding specificity could be transferred, but surrounding residues can influence the binding-site geometry; affinity must be rechecked after engineering.^[ref] Humanization reduces some sources of immunogenicity without proving that the final molecule cannot elicit an immune response.

A second route is antibody phage display. A library encodes antibody fragments fused to a phage coat protein, while each particle carries the corresponding genetic information. Repeated antigen binding, washing, recovery and amplification enrich binders. The original display experiments established the physical linkage between antibody-variable-domain binding and the sequence that encodes it.^[ref] For Colonumab, positive selection on native tumour target should be combined with counterselection against relevant normal cells, tag components and unrelated proteins. Immobilized-antigen binders can recognize exposed plastic-associated conformations or show display-dependent avidity, so selected fragments must be tested as soluble molecules and after reformatting into full IgG. Human donor B-cell cloning or immunization of animals carrying human immunoglobulin loci provide additional routes to human-sequence candidates.

Lead optimization combines affinity maturation, epitope mapping and functional screening. For a simple one-to-one interaction, $K_D=k_{\mathrm{off}}/k_{\mathrm{on}}$, but bivalent binding on a dense cell surface introduces avidity. surface plasmon resonance or another binding method should therefore use controls for ligand density, transport limitation and nonspecific binding. Higher affinity is not automatically better: tissue penetration, target internalization, aggregation and off-target binding also matter. Choice of antibody constant region determines properties such as effector-cell engagement and persistence; it must match the intended action.

A selected sequence can be expressed in a stable mammalian production line, commonly Chinese hamster ovary cells, and purified by protein A affinity chromatography followed by additional purification and formulation steps. The final product needs identity, purity, aggregation, glycosylation, stability and potency assays. Functional tests should compare isotype control, target-negative cells and, where relevant, an effector-silent or binding-fragment derivative to separate direct blockade from immune-mediated killing. Animal studies require a species or model in which the target and effector biology are relevant; an immunodeficient xenograft alone cannot establish normal human immune-effector activity. A binding clone becomes a therapeutic candidate only after specificity, mechanism, production quality and a plausible therapeutic window have been demonstrated; the paper supplies no data establishing that Colonumab already meets those criteria.

Dinoflagellate nuclear DNA is generally organized with far fewer canonical nucleosomes and a very different bulk packing architecture from that of familiar animal, plant and fungal nuclei. This is not equivalent to saying that dinoflagellates have no histones. The comparison must concern nuclear chromosomes, not bacterial nucleoids or organellar DNA, and must allow variation across dinoflagellate lineages.

In conventional chromatin, about $147$ base pairs of DNA wrap around an octamer containing two copies each of the core histones H2A, H2B, H3 and H4, forming a nucleosome. Linker DNA joins neighbouring particles, and histone H1 can influence linker organization. Nucleosomes compact DNA, regulate accessibility and provide substrates for histone modification and chromatin-remodelling machinery. Their spacing and higher-order contacts vary; a universal regular 30-nanometre fibre should not be assumed for all living nuclei. Wrapping is left-handed at the superhelical level, while the local duplex remains mainly right-handed B-DNA; this is not conversion of the duplex into Z-DNA.

Many dinoflagellates instead maintain conspicuously condensed chromosomes through interphase as well as division. Dense DNA arrays show liquid-crystalline chromosome organization, with ordered packing unlike a conventional beads-on-a-string nucleosomal array. Many species also have unusually large genomes and a low bulk basic-protein-to-DNA ratio. These are broad comparative trends, not proof that every dinoflagellate has the same genome size, protein complement or microscopic packing. Divalent ions, supercoiling and nonhistone DNA-binding proteins can contribute to organization, but the complete in vivo packing mechanism is not resolved by the appearance of condensed chromosomes alone.

A major discovery was the family of dinoflagellate viral nucleoproteins (DVNP). Comparative work linked the emergence of abundant DVNPs with reduced histone abundance and loss of ordinary nucleosomal organization in early-diverging dinoflagellates. These basic nuclear proteins have homologues in large DNA viruses and can associate with chromosomes.^[ref] Sequence similarity supports an evolutionary relationship; it does not by itself establish the direction of gene transfer, the exact ancestral event or the packaging role of each modern family member. Some later lineages additionally use dinoflagellate histone-like proteins, distinct from the conserved eukaryotic core histones and related in sequence to bacterial HU-type DNA-binding proteins. Calling both groups “histone-like” must not erase that distinction.

Modern sequence and protein evidence reveals retained core-histone genes and low-abundance histones in dinoflagellates. Their presence argues against an absolute histone-free description, but does not imply that they package most of the genome conventionally. They may have specialized roles; their genome-wide occupancy and precise functions need direct testing. Conversely, absence of a strong histone band in a bulk extract is not proof of complete absence, because recovery, antibody cross-reactivity and detection limits can differ among species.

The evidence comes from complementary experiments. Microscopy and chromosome birefringence test large-scale order, while nuclease digestion can test whether protected DNA fragments form a regular nucleosome-sized ladder. Standard eukaryotic chromatin is a positive control; naked DNA, undigested material and enzyme-dose series control digestion behaviour. A missing ladder is consistent with altered organization but can also result from overdigestion or unusual accessibility. Proteomics, histone-directed immunodetection and localization of candidate DNA-binding proteins address composition, while quantitative normalization to DNA is required for meaningful abundance comparisons.

A mechanistic perturbation was expression of a dinoflagellate DVNP in Saccharomyces cerevisiae. It impaired growth, associated with sites normally occupied by histones, displaced nucleosomes and impaired transcription; reducing histone abundance alleviated the toxicity.^[ref] This supports antagonism between DVNP and canonical chromatin in the tested system. Expression controls and histone manipulations help distinguish specific chromatin competition from generic protein-expression stress. However, an ectopic yeast experiment does not reconstruct the actual history of dinoflagellate evolution or establish the whole structure of a native dinoflagellate chromosome. The secure distinction is replacement of canonical nucleosomes as the dominant bulk packaging system, with retained but reduced histones and lineage-dependent alternative nucleoproteins.

Transient chemotaxis complexes have been investigated by combining biochemical reconstitution, live-cell proximity measurements, interface mapping and structural imaging. No single interaction assay establishes all of binding, signalling function and physiological timing. In the Escherichia coli pathway, methyl-accepting chemotaxis proteins form receptor assemblies with CheW and the histidine kinase CheA. Receptor stimulation regulates CheA autophosphorylation; phosphate transfer to CheY couples the input to the flagellar switch, while CheZ accelerates CheY dephosphorylation. Some receptor-scaffold contacts are relatively persistent, whereas downstream enzyme–substrate encounters are short-lived, so the premise should not imply one common lifetime for every contact.

Biochemical reconstitution first connects components to a function. Receptor-containing membranes and purified signalling proteins can be combined, supplied with labelled ATP and analysed by rapid sampling and electrophoretic separation to follow phosphorylation. Omitting and restoring CheW or another component tests its requirement, while adding the receptor's attractant tests coupling across the membrane. Reconstitution of receptor-dependent control of CheY phosphorylation established a biochemical pathway linking the receptor, CheA and response regulator.^[ref] Catalytically inactive CheA, no-ATP, no-receptor and no-ligand comparisons distinguish substrate phosphorylation from nonspecific label retention. Dependence on two proteins is functional evidence, however, not proof that they touch directly: a third protein can bridge them.

Affinity capture, co-immunoprecipitation and co-fractionation can identify associated partners, but washing can lose weak contacts and overexpression can force nonphysiological ones. A purified pair helps distinguish direct binding from bridging. Rapid or site-directed crosslinking can trap close contacts before they dissociate; complementary substitutions and compensatory mutations can then test a candidate interface. No-crosslinker, single-reactive-residue and noninteracting-partner controls are important, as are checks that the mutant proteins remain folded, localized and functional. Crosslink recovery establishes proximity within the reagent's constraints rather than a complete native binding geometry.

Förster resonance energy transfer provides a particularly informative live-cell readout. In the established chemotaxis FRET assay, CheZ fused to a cyan donor and CheY fused to a yellow acceptor report their close association. Phosphorylated CheY preferentially associates with its phosphatase, so an attractant-induced reduction in CheA activity produces a rapid decrease in the association-dependent FRET signal. Stimulus addition, removal and adaptation can therefore be followed in living cells. The original measurements used this downstream readout to probe receptor sensitivity, including receptor-modification backgrounds.^[ref]

The FRET signal is not a direct measurement of receptor–CheA binding. It depends on phosphotransfer, CheY–CheZ association, label geometry and fluorescent-protein behaviour. Donor-only and acceptor-only cells control spectral bleed-through and direct excitation; expression titration, background subtraction and photobleaching controls limit optical artefacts. Testing whether tagged proteins restore a relevant mutant phenotype checks perturbation by the labels. A binding-interface mutant should be compared with a phosphorylation-defective mutant, because either could abolish the same signal through different mechanisms. Distance-dependent transfer can be summarized as $E=1/[1+(r/R_0{)}^6]$, but converting an ensemble signal into a unique molecular distance requires assumptions about orientation and conformational heterogeneity.

nuclear magnetic resonance can map contacts at residue level. Binding-induced chemical-shift changes in labelled fragments identify affected surfaces and permit titration analysis. Work with Thermotoga maritima components mapped a receptor-contact surface on the CheA P5 domain and tested corresponding mutations in Escherichia coli using kinase activation and chemotaxis assays.^[ref] Chemical-shift perturbations can include allosteric changes as well as direct contact, and a soluble fragment can omit membrane or array constraints. Agreement among binding measurements, conservative interface mutations and preserved basal catalytic activity provides a stronger interpretation than loss of chemotaxis alone. A soft-agar migration defect can also reflect altered growth or motility rather than a particular binding defect.

Structural methods establish how such contacts fit into larger assemblies. Crystallography of domains can resolve plausible contact surfaces, while electron cryotomography images receptor arrays in near-native cells. Comparative tomography revealed a conserved approximately $12\mathrm{nm}$ hexagonal array consistent with receptor trimers of dimers.^[ref] This supports cooperative array architecture but does not directly measure the lifetime of an individual CheY encounter. Localization microscopy adds cellular position and dynamics, with resolution and labelling limits that must be stated.

The most persuasive strategy is therefore to identify a candidate contact physically, disrupt it without destroying the component, show the predicted effect in a reconstituted pathway and test the corresponding response in living cells. Adaptation studies further show why kinetic measurements matter: an interaction-dependent readout can recover after sustained input even though the stimulus remains present.^[ref] Combining controlled perturbation with independent binding, activity and cellular readouts distinguishes a real signalling interface from simple colocalization or correlated behaviour.